Published in Neth Heart J on February 01, 2004
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature (1999) 12.32
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev (1998) 7.81
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A (1999) 5.78
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A (2000) 3.95
Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation (2010) 2.53
Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology (2008) 2.21
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol (2000) 2.12
Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators? Neth Heart J (2011) 1.89
Bibliometric data in clinical cardiology revisited. The case of 37 Dutch professors. Neth Heart J (2011) 1.79
Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet (2005) 1.78
Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties. Acta Physiol Scand (2005) 1.67
[Initial diagnostic strategy in the case of transient losses of consciousness: the importance of the medical history]. Ned Tijdschr Geneeskd (2003) 1.55
Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J (2003) 1.52
Laparoscopy as the investigation and treatment of choice for urinary incontinence caused by small 'invisible' dysplastic kidneys with infrasphincteric ureteric ectopia. BJU Int (1999) 1.47
[Genetic identification of patients and families with a long-QT syndrome: large regional differences in the result of 10 years]. Ned Tijdschr Geneeskd (2007) 1.46
The works of Dirk Durrer (1918-1984). Neth Heart J (2012) 1.39
[Medication for ADHD and the risk of cardiovascular mortality]. Ned Tijdschr Geneeskd (2006) 1.39
Pyloromyotomy: comparison between laparoscopic and open surgical techniques. J Laparoendosc Surg (1995) 1.37
The Hirsch-index: a simple, new tool for the assessment of scientific output of individual scientists: The case of Dutch professors in clinical cardiology. Neth Heart J (2009) 1.30
Hevein, a lectin-like protein from Hevea brasiliensis (rubber tree) is involved in the coagulation of latex. J Biol Chem (1994) 1.21
The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. J Med Genet (2003) 1.13
The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol (2009) 1.11
Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology (1995) 1.09
Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology (2009) 1.00
Biological pacing by gene and cell therapy. Neth Heart J (2007) 0.99
Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Ann Med (2004) 0.98
Passive chloride permeability charge coupled to H(+)-ATPase of avian osteoclast ruffled membrane. Am J Physiol (1991) 0.97
Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case-control study. Eur J Clin Microbiol Infect Dis (2010) 0.95
Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome. Neth Heart J (2010) 0.94
First experience with the wearable cardioverter defibrillator in the Netherlands. Neth Heart J (2012) 0.94
Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy. Neth Heart J (2013) 0.94
Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes. Neth Heart J (2014) 0.93
Short-coupled variant of torsade de pointes. Neth Heart J (2008) 0.93
Early experience with laparoscopic pyloromyotomy for infantile hypertrophic pyloric stenosis. J Pediatr Surg (1995) 0.92
Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands. Neth Heart J (2010) 0.92
Laparoscopic dismembered pyeloplasty in children younger than 2 years. J Urol (2007) 0.92
The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease. Neth Heart J (2011) 0.91
Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Neth Heart J (2010) 0.91
Rationale and design of the CAREFUL study : The yield of CARdiogenetic scrEening in First degree relatives of sudden cardiac and UnexpLained death victims <45 years. Neth Heart J (2010) 0.90
Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology (2011) 0.90
Extracellular-matrix degradation at acid pH. Avian osteoclast acid collagenase isolation and characterization. Biochem J (1993) 0.89
Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome. Am J Med Genet A (2005) 0.88
Reduced in-hospital survival rates of out-of-hospital cardiac arrest victims with obstructive pulmonary disease. Resuscitation (2012) 0.88
High distress in parents whose children undergo predictive testing for long QT syndrome. Community Genet (2005) 0.87
Priapism in childhood. Br J Urol (1989) 0.87
Prognostic value of microvolt T-wave alternans in a real-world ICD population. Twente ICD Cohort Studie (TICS). Neth Heart J (2014) 0.87
A review of pediatric cases of urinary tract calculi. J Pediatr Surg (1994) 0.86
Accuracy of various iron parameters in the prediction of iron deficiency in an acute care hospital. Ann Acad Med Singapore (2005) 0.86
IL-1-induced murine osteoblast IL-6 production is mediated by the type 1 IL-1 receptor and is increased by 1,25 dihydroxyvitamin D3. J Clin Invest (1993) 0.85
Assessment of stem cell markers during long-term culture of mouse embryonic stem cells. Cytotechnology (2004) 0.85
Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey. Clin Genet (2005) 0.85
Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation? Neth Heart J (2007) 0.84
Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers. Neth Heart J (2009) 0.84
Clinical outcomes for cancer patients using complementary and alternative medicine. Altern Ther Health Med (2012) 0.83
Pregnancy and the risk of torsades de pointes in congenital long-QT syndrome. Neth Heart J (2008) 0.83
Single-increment dilatation for percutaneous renal surgery: an experimental study. Br J Urol (1991) 0.83
Accuracy of serum transferrin receptor levels in the diagnosis of iron deficiency among hospital patients in a population with a high prevalence of thalassaemia trait. Int J Lab Hematol (2008) 0.81
Rapid reversal of coagulopathy in warfarin-related intracranial haemorrhages with prothrombin complex concentrates. Anaesth Intensive Care (2010) 0.81
Laparoscopic surgery in children is associated with an intraoperative hypermetabolic response. Surg Endosc (2006) 0.81
Osteoprotegerin inhibits tumor-induced osteoclastogenesis and bone tumor growth in osteopetrotic mice. J Orthop Res (2000) 0.81
GENCOR: a national registry for patients and families suffering from a familial heart disease in the Netherlands. Neth Heart J (2006) 0.81
Netherlands Heart Journal: accepted into PubMed Central! Neth Heart J (2006) 0.81
Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy. Neth Heart J (2007) 0.81
Reversible inhibition of osteoclastic activity by bone-bound gallium (III). J Cell Biochem (1992) 0.80
Recurrent and Founder Mutations in the Netherlands: the Long-QT Syndrome. Neth Heart J (2010) 0.80
Letter regarding article by McNair et al, "SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia". Circulation (2005) 0.80
Electrophysiologic and extracellular ionic changes during acute ischemia in failing and normal rabbit myocardium. J Mol Cell Cardiol (1996) 0.80
Recurrent and founder mutations in inherited cardiac diseases in the Netherlands. Neth Heart J (2009) 0.80
Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6. Neth Heart J (2011) 0.80
Laparoscopic repair of inguinal hernias in children. J Pediatr Surg (2001) 0.80
Percutaneous pulmonary valve replacement: a new development in the lifetime strategy for patients with congenital heart disease. Neth Heart J (2007) 0.79
[Hypertrophic cardiomyopathy: a genetically-carried heart disease]. Ned Tijdschr Geneeskd (2002) 0.79
Cellular basis of sex disparities in human cardiac electrophysiology. Acta Physiol (Oxf) (2006) 0.79
Ca2+-activated Cl- current reduces transmural electrical heterogeneity within the rabbit left ventricle. Acta Physiol Scand (2004) 0.78
Ferulic acid induces heme oxygenase-1 via activation of ERK and Nrf2. Drug Discov Ther (2011) 0.77
Towards a better risk stratification for sudden cardiac death in patients with structural heart disease. Neth Heart J (2009) 0.77
Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters. Neth Heart J (2007) 0.77
Flush after syncope: not always an arrhythmia. J Cardiovasc Electrophysiol (2006) 0.77
A large family characterised by nocturnal sudden death. Neth Heart J (2002) 0.77
Murine osteoblast interleukin 4 receptor expression: upregulation by 1,25 dihydroxyvitamin D3. J Cell Biochem (1993) 0.77
T-wave alternans in a patient with long-QT syndrome type 3. Neth Heart J (2006) 0.77
Interleukin 4 increases type 5 acid phosphatase mRNA expression in murine bone marrow macrophages. J Cell Biochem (1994) 0.77
De novo mutation in the KCNQ1 gene causal to Jervell and Lange-Nielsen syndrome. Clin Genet (2013) 0.76
Role of Ca2+-activated Cl- current during proarrhythmic early afterdepolarizations in sheep and human ventricular myocytes. Acta Physiol Scand (2003) 0.76
Genetic predisposition for sudden cardiac death in myocardial ischaemia: the Arrhythmia Genetics in the NEtherlandS study. Neth Heart J (2011) 0.76
Limited role of Ca(2+)-activated Cl(-) current in early afterdepolarisations. Neth Heart J (2002) 0.75
TDI-echocardiography: a new screening tool for long QT syndrome? Eur J Echocardiogr (2003) 0.75
Familial primary arrhythmia syndromes: Nice to know or need to know. Neth Heart J (2002) 0.75
COMPANION - a friend indeed. Neth Heart J (2003) 0.75
Brugada syndrome. Eur Heart J (2002) 0.75